Caelum, Alexion Present Additional Data for CAEL-101 to Help Improve Cardiac, Renal Conditions

Retrieved on: 2021-06-15 14:48:45

Tags for this article:

Click the tags to see associated articles and topics

Caelum, Alexion Present Additional Data for CAEL-101 to Help Improve Cardiac, Renal Conditions. View article details on hiswai:

Excerpt

Together, Caelum Biosciences and Alexion Pharmaceuticals presented new Phase 2 safety and tolerability data for CAEL-101, a monoclonal antibody ...

Article found on: www.sciencetimes.com